208 related articles for article (PubMed ID: 21969138)
1. Klotho is silenced through promoter hypermethylation in gastric cancer.
Wang L; Wang X; Wang X; Jie P; Lu H; Zhang S; Lin X; Lam EK; Cui Y; Yu J; Jin H
Am J Cancer Res; 2011; 1(1):111-119. PubMed ID: 21969138
[TBL] [Abstract][Full Text] [Related]
2. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
[TBL] [Abstract][Full Text] [Related]
3. Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer.
Pan J; Zhong J; Gan LH; Chen SJ; Jin HC; Wang X; Wang LJ
Tumour Biol; 2011 Aug; 32(4):729-35. PubMed ID: 21523445
[TBL] [Abstract][Full Text] [Related]
4. Klotho promoter methylation status and its prognostic value in ovarian cancer.
Al-Zahrani MH; Yahya FM; Assidi M; Dallol A; Buhmeida A
Mol Clin Oncol; 2021 Sep; 15(3):181. PubMed ID: 34277000
[TBL] [Abstract][Full Text] [Related]
5. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
Cheng YY; Jin H; Liu X; Siu JM; Wong YP; Ng EK; Yu J; Leung WK; Sung JJ; Chan FK
Br J Cancer; 2008 Dec; 99(12):2083-7. PubMed ID: 18985039
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
7. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.
Wang L; Chen S; Xue M; Zhong J; Wang X; Gan L; Lam EK; Liu X; Zhang J; Zhou T; Yu J; Jin H; Si J
Mol Med; 2012 May; 18(1):389-400. PubMed ID: 22160393
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma.
Xie B; Zhou J; Yuan L; Ren F; Liu DC; Li Q; Shu G
Hum Pathol; 2013 May; 44(5):795-801. PubMed ID: 23123137
[TBL] [Abstract][Full Text] [Related]
10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of
Perveez M; Ajaz M; Afroze D
Mol Biol Res Commun; 2015 Dec; 4(4):217-224. PubMed ID: 27844013
[TBL] [Abstract][Full Text] [Related]
12. The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.
Haag T; Herkt CE; Walesch SK; Richter AM; Dammann RH
Genes Cancer; 2014 Sep; 5(9-10):365-74. PubMed ID: 25352953
[TBL] [Abstract][Full Text] [Related]
13. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
Meng CF; Zhu XJ; Peng G; Dai DQ
World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
[TBL] [Abstract][Full Text] [Related]
14. Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer.
Zhang D; Zhao W; Liao X; Bi T; Li H; Che X
Oncol Rep; 2012 Nov; 28(5):1785-91. PubMed ID: 22941331
[TBL] [Abstract][Full Text] [Related]
15. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
16. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma.
Kim J; Min SY; Lee HE; Kim WH
Int J Cancer; 2012 Feb; 130(4):817-26. PubMed ID: 21387304
[TBL] [Abstract][Full Text] [Related]
18. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.
Du W; Wang S; Zhou Q; Li X; Chu J; Chang Z; Tao Q; Ng EK; Fang J; Sung JJ; Yu J
Oncogene; 2013 Jul; 32(28):3319-28. PubMed ID: 22907434
[TBL] [Abstract][Full Text] [Related]
19. Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells.
Yoon D; Bae K; Lee MK; Kim JH; Yoon KA
PLoS One; 2018; 13(2):e0193275. PubMed ID: 29462183
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development.
Yang W; Mok MT; Li MS; Kang W; Wang H; Chan AW; Chou JL; Chen J; Ng EK; To KF; Yu J; Chan MW; Chan FK; Sung JJ; Cheng AS
Oncogene; 2016 Apr; 35(16):2133-44. PubMed ID: 26212015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
